Amgen Inc.
US ˙ NasdaqGS ˙ US0311621009

SecurityAMGN / Amgen Inc.
InstitutionAxa S.a.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Axa S.a. closes position in AMGN / Amgen Inc.

On November 14, 2025 - Axa S.a. filed a 13F-HR form disclosing ownership of 0 shares of Amgen Inc. (US:AMGN) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 379,296 shares of Amgen Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F AMGEN COM 031162100 0 -379,296 -100.00 0 -100.00
2025-08-14 2025-06-30 13F AMGEN COM 031162100 379,296 103,665 37.61 105,903 23.33 0.3042
2025-05-15 2025-03-31 13F AMGEN COM 031162100 275,631 3,951 1.45 85,873 21.27 0.2821
2025-02-14 2024-12-31 13F AMGEN COM 031162100 271,680 -89,434 -24.77 70,811 -39.14 0.2151
2024-11-14 2024-09-30 13F AMGEN COM 031162100 361,114 71,737 24.79 116,355 28.69 0.3445
2025-02-25 2024-06-30 13F/A-1 AMGEN COM 031162100 289,377 -291,992 -50.22 90,416 -45.30 0.2690
2024-08-14 2024-06-30 13F AMGEN COM 031162100 289,377 -291,992 90,416 0.2690
2024-05-15 2024-03-31 13F AMGEN COM 031162100 581,369 -5,350 -0.91 165,295 -2.18 0.4955
2024-07-16 2023-12-31 13F/A-1 AMGEN COM 031162100 586,719 -2,243 -0.38 168,987 6.76 0.5449
2024-02-14 2023-12-31 13F AMGEN COM 031162100 586,719 -2,243 168,987 0.3309
2023-11-14 2023-09-30 13F AMGEN COM 031162100 588,962 73,400 14.24 158,289 38.29 0.5564
2023-08-14 2023-06-30 13F AMGEN COM 031162100 515,562 34,543 7.18 114,465 -1.57 0.3804
2023-05-15 2023-03-31 13F AMGEN COM 031162100 481,019 128,794 36.57 116,286 25.70 0.4000
2023-02-14 2022-12-31 13F AMGEN COM 031162100 352,225 3,028 0.87 92,508 17.53 0.3338
2023-02-14 2022-09-30 13F/A-1 Amgen COM 031162100 349,197 13,716 4.09 78,709 -3.57 0.3096
2022-11-14 2022-09-30 13F Amgen COM 031162100 349,197 13,716 78,709 0.3097
2023-02-14 2022-06-30 13F/A-1 Amgen COM 031162100 335,481 -14,110 -4.04 81,623 -3.45 0.3025
2022-08-15 2022-06-30 13F Amgen COM 031162100 335,481 -14,110 81,623 0.3025
2023-02-14 2022-03-31 13F/A-1 Amgen COM 031162100 349,591 -78,467 -18.33 84,538 -12.21 0.2403
2022-05-13 2022-03-31 13F Amgen COM 031162100 349,591 -78,467 84,538 0.2403
2022-02-14 2021-12-31 13F Amgen COM 031162100 428,058 662 0.15 96,300 5.96 0.2462
2021-11-15 2021-09-30 13F Amgen COM 031162100 427,396 -2,165 -0.50 90,885 -13.20 0.2551
2021-08-13 2021-06-30 13F/A-1 Amgen COM 031162100 429,561 -83,120 -16.21 104,705 -17.92 0.2952
2021-08-13 2021-06-30 13F Amgen COM 031162100 429,561 -83,120 104,705 0.1768
2021-05-14 2021-03-31 13F Amgen COM 031162100 512,681 -14,215 -2.70 127,559 5.29 0.3884
2021-02-12 2020-12-31 13F Amgen COM 031162100 526,896 436 0.08 121,145 -9.46 0.3802
2021-02-11 2020-09-30 13F/A-1 Amgen COM 031162100 526,460 -52,876 -9.13 133,805 -2.08 0.4836
2020-11-13 2020-09-30 13F Amgen COM 031162100 526,460 -52,876 133,805 267,096.0165
2021-02-12 2020-06-30 13F/A-1 AMGEN COM 031162100 579,336 -11,776 -1.99 136,642 14.02 0.5383
2020-08-14 2020-06-30 13F AMGEN COM 031162100 579,336 -11,776 136,642 538,867.6673
2021-02-12 2020-03-31 13F/A-2 AMGEN COM 031162100 591,112 122,130 26.04 119,837 6.00 0.5990
2020-06-15 2020-03-31 13F/A-1 AMGEN COM 031162100 591,112 0 119,837 0.5994
2020-05-15 2020-03-31 13F AMGEN COM 031162100 591,112 122,130 119,837 333,268.7581
2021-02-12 2019-12-31 13F/A-1 AMGEN COM 031162100 468,982 26,426 5.97 113,057 32.02 0.4598
2020-02-18 2019-12-31 13F AMGEN COM 031162100 468,982 26,426 113,057 460,329.4484
2021-02-12 2019-09-30 13F/A-1 AMGEN COM 031162100 442,556 28,450 6.87 85,639 12.22 0.3408
2019-11-14 2019-09-30 13F AMGEN COM 031162100 442,556 28,450 85,639 341,276.8670
2021-02-12 2019-06-30 13F/A-1 AMGEN COM 031162100 414,106 51,862 14.32 76,312 10.89 0.2979
2019-08-13 2019-06-30 13F AMGEN COM 031162100 414,106 51,862 76,312 299,263.5666
2019-05-14 2019-03-31 13F AMGEN COM 031162100 362,244 -27,328 -7.01 68,819 -9.26 0.2689
2019-02-13 2018-12-31 13F AMGEN COM 031162100 389,572 -109,235 -21.90 75,838 -26.65 0.3306
2018-11-08 2018-09-30 13F AMGEN COM 031162100 498,807 7,341 1.49 103,398 13.97 0.3792
2018-08-13 2018-06-30 13F AMGEN COM 031162100 491,466 -246,074 -33.36 90,720 -27.85 0.3477
2018-05-14 2018-03-31 13F AMGEN COM 031162100 737,540 -358,999 -32.74 125,735 -34.06 0.5018
2018-02-13 2017-12-31 13F AMGEN COM 031162100 1,096,539 125,375 12.91 190,689 5.31 0.7488
2017-12-01 2017-09-30 13F/A-1 AMGEN COM 031162100 971,164 -2,921 -0.30 181,074 7.93 0.7800
2017-11-13 2017-09-30 13F AMGEN COM 031162100 971,164 -2,921 181,074
2017-08-10 2017-06-30 13F AMGEN COM 031162100 974,085 -104,179 -9.66 167,767 -5.17 0.7616
2017-05-11 2017-03-31 13F AMGEN COM 031162100 1,078,264 -125,265 -10.41 176,911 0.54 0.7987
2017-02-13 2016-12-31 13F AMGEN COM 031162100 1,203,529 -152,675 -11.26 175,968 -22.22 0.8257
2016-11-10 2016-09-30 13F AMGEN COM 031162100 1,356,204 116,530 9.40 226,228 19.94 0.9938
2016-08-11 2016-06-30 13F AMGEN COM 031162100 1,239,674 -336,899 -21.37 188,617 -20.20 0.8403
2016-05-13 2016-03-31 13F AMGEN COM 031162100 1,576,573 -6,075 -0.38 236,375 -7.99 1.0603
2016-02-12 2015-12-31 13F AMGEN COM 031162100 1,582,648 -820,834 -34.15 256,911 -22.72 1.1227
2015-11-13 2015-09-30 13F AMGEN COM 031162100 2,403,482 -217,120 -8.29 332,450 -17.37 1.3631
2015-08-13 2015-06-30 13F AMGEN COM 031162100 2,620,602 -62,099 -2.31 402,315 -6.18 1.6105
2015-05-13 2015-03-31 13F AMGEN COM 031162100 2,682,701 235,659 9.63 428,830 10.02 1.7673
2015-02-13 2014-12-31 13F AMGEN COM 031162100 2,447,042 -130,507 -5.06 389,789 7.66 1.5637
2014-11-13 2014-09-30 13F AMGEN COM 031162100 2,577,549 -238,515 -8.47 362,042 8.61 1.5478
2014-08-13 2014-06-30 13F AMGEN COM 031162100 2,816,064 -35,875 -1.26 333,337 -5.24 1.3868
2014-05-13 2014-03-31 13F AMGEN COM 031162100 2,851,939 95,342 3.46 351,758 11.78 1.5302
2014-02-13 2013-12-31 13F AMGEN COM 031162100 2,756,597 94,000 3.53 314,693 5.58 1.4090
2013-11-13 2013-09-30 13F AMGEN COM 031162100 2,662,597 212,356 8.67 298,051 23.29 1.4681
2013-08-12 2013-06-30 13F AMGEN COM 031162100 2,450,241 2,450,241 241,740 1.2841
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.